João Manuel P.

The Chairman UCEA Single Family Office

📍 United Kingdom🔄 Updated September 2026💼 12 investments📅 3 years investing🗓 Last invested Feb 2025
VC🌍 United Kingdom
12
Total investments
0
Early stage
3
Mid stage
6
Late stage
3y
Years active

Portfolio

10 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Private Investor
Feb 2025
Freedom Biosciences is a clinical-stage biotechnology platform developing next-generation neuropsychiatric therapeutics. Through its discovery platform, Freedom Biosciences has identified the most efficacious combinations of chemicals to advance the safety and therapeutic profiles of existing therapeutics. With programs with clinical data and multiple exploratory programs, Freedom Biosciences has a diverse portfolio of assets that are positioned to significantly change the way we treat mental health indications. Freedom Biosciences is co-founded by Dr. John Krystal and Dina Burkitbayeva. Dr. John Krystal is the Chair of the Department of Psychiatry at Yale University and Chief of Psychiatry and Behavioral Health at Yale-New Haven Hospital. Dina Burkitbayeva is a co-founder of PsyMed Ventures.
Investor
Feb 2025
Based in Norway, Recharge Health is a team of innovators dedicated to unlocking the full potential of the human body. Through collaboration with doctors and researchers worldwide, weve created FlexBeam, a revolutionary recovery device utilizing targeted infrared light therapy. Our mission is to bring the power of infrared light therapy into every home. More on FlexBeam: FlexBeam is the most powerful infrared therapy device of its kind. This non-pharmaceutical, non-invasive solution is already making a significant impact on the lives of many. With over 20,000 satisfied customers worldwide and endorsements from notable, global athletes, this wearable recovery device is changing the game of athletic recovery and health optimization. Developed with NASA-inspired technology, FlexBeam uses infrared light therapy to deliver powerful wavelengths of red (610-650nm) and infrared (800-850nm) light at up to 110mW/cm2, and a total optical power output of 5.5W. This powerful and targeted light stimulates your cells to produce more energy – so you can repair muscle, relieve pain, and recover faster.
Investor and Board Member
Feb 2025
To be more responsive, more efficient and make better decisions, BforCure allows public and industrial stakeholders to access biological information in real time, thanks to an innovative technology of rapid biodetection.
Investor and Board Member
Feb 2025
Puredrive Energy can call upon over 10 years of experience in the development, deployment and placement of battery technologies. With extensive experience in lead acid batteries through to the latest Lithium Ion batteries, Puredrive Energy is at the forefront of battery centric energy storage systems. Building upon its extensive market knowledge across Marine, Leisure, Sports , Mobility, UPS and Industrial Puredrive Energy has worked in conjunction with Puredrive to design and build a unique range of Energy Storage systems that are aimed at the Residential, Commercial and Community Battery Storage markets. Puredrive Energy’s unique (in house designed) battery is at the heart of all its products, and when packaged with other exclusive (Puredrive Energy) technical components, helps deliver a set of market leading products that are flexible, robust and offering excellent value for money. The Puredrive Energy range of products has been born out of over 10 years of market and customer experience. Consistently delivering richly featured products which meet the main needs of its customer’s requirements. Puredrive Energy Ltd is a British company that designs, develops, builds and distributes its own products to a broad spectrum of clients both home and abroad. With UK assembly of its products it is ideally placed to exploit its clearly established supply chain to maximum effect. Making delivery and distribution, in volume, to its UK market place speedy and simple. “PUREDRIVE ENERGY – A PURE JOY TO WORK WITH”
Investor and Board Member
Oct 2024
LifeQ is the leading provider of biometrics and health information derived from wearable devices, helping people live healthier lives. By providing a 24/7 lens into the body, LifeQ’s solutions go beyond an everyday smartwatch, generating business-grade biometrics for consumers, athletes, and the acutely and chronically ill—detecting health problems and preventing illness. From cardiovascular disease and COVID to respiratory disorders and sleep apnea, LifeQ enables early detection and treatment of the world’s most debilitating diseases. Consumers, wearable device companies, insurers and reinsurers, health-tech companies, clinicians, researchers, and analytics companies all benefit from LifeQ’s powerful disease detection and prevention capabilities—representing the future of healthcare.
Investors and Board Member
Sep 2024
Graphiant is a Silicon Valley-based provider of next-generation Edge services. Graphiant has developed the Graphiant Network Edge, an “as-a-Service” solution that provides connectivity between the enterprise WAN, hybrid cloud, network edge, customers, and partners. Graphiant’s Network Edge combines MPLS-like performance (guaranteed delivery and privacy) and Internet-class agility to enable network architects to build enterprise-grade networks at the speed of business.
Investor
Sep 2024
Our mission is to improve the overall health and well-being of our members. Making healthcare simple, personal and affordable by delivering on our commitments. We are based and built in Atlanta. We call Atlanta our home and the people of Atlanta our neighbors. We are Georigans serving Georgians.
Investor & Board Observer
Apr 2024
BoltOS is a system upgrade for creators. Founded in 2017, BoltOS is a technology company that combines immersive streaming with accessible blockchain technology to create a unique ecosystem for creators, viewers, and advertisers. The heart of our ecosystem is the Bolt+ live streaming platform (boltplus.tv), which offers free, advertising-supported streaming from individual creators, some of the biggest media companies in the world, and everyone in between. At Bolt+, our unique immersive streaming technology empowers viewers to interact with content through features like Chat, Shop, Rewards, and AI. Bolt+ also hosts live events and subscription-only content, offering monetisation opportunities for creators. Weve also enabled programmatic advertising, enabling blue-chip advertisers to reach audiences on Bolt+. AI and ML implementations is enabled by our integration of 6 foundational models (including Claude and Llama3) across Bolt+. BoltChain, an Ethereum-compatible Blockchain with smart contract support, and BoltX, our digital asset wallet, come together with Bolt+ to supercharge the BoltOS offering. BoltOS has forged strategic relationships with over 180 TV brands, streaming partnerships with 50 media giants, and 30 technology partners. Some of our strategic partners include Bloomberg, Hisense Group, and One Football. At the heart of BoltOS is a diverse team that originates from 15 different countries, including alumni from Tencent, Twitter, and Goldman Sachs. BoltOS is headquartered in London, United Kingdom, and backed by Trovio Group , MBK Holdings (Qatar Royal Family), Primal Capital, and Plutus Investment Group. We have a diverse and inclusive team, where 40% of our executive leadership team are women. Links: boltos.ai, boltplus.tv, boltchain.com
Investor & Board Observer
Mar 2024
We are a clinical stage company developing novel therapeutics inspired by kanna, or Sceletium tortuosum. Kanna is a medicinal succulent traditionally used by the San hunter-gatherers of South Africa.
Board Member and Investor
Dec 2023
Formed in late 2017, AMLo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify patients’ true risk of disease progression. Those patients who are genuinely at low-risk of disease spread can be provided reassurance and better-informed follow-up care, while those identified at risk of metastasis are enabled to receive timely treatment. The test under development – AMBLor® – will be simple to use and fits seamlessly into current diagnostic practice. AMLo Biosciences has been founded by a team with an internationally acclaimed research track record in the melanoma field, through identification of translational biomarkers, drug discovery & development and the building of biotech companies.
Experience · 16 entries
All (16)
Investments (12)
Board (7)
2025
Private Investor
Feb 2025
Freedom Biosciences is a clinical-stage biotechnology platform developing next-generation neuropsychiatric therapeutics. Through its discovery platform, Freedom Biosciences has identified the most efficacious combinations of chemicals to advance the safety and therapeutic profiles of existing therapeutics. With programs with clinical data and multiple exploratory programs, Freedom Biosciences has a diverse portfolio of assets that are positioned to significantly change the way we treat mental health indications. Freedom Biosciences is co-founded by Dr. John Krystal and Dina Burkitbayeva. Dr. John Krystal is the Chair of the Department of Psychiatry at Yale University and Chief of Psychiatry and Behavioral Health at Yale-New Haven Hospital. Dina Burkitbayeva is a co-founder of PsyMed Ventures.
Investor
Feb 2025
Based in Norway, Recharge Health is a team of innovators dedicated to unlocking the full potential of the human body. Through collaboration with doctors and researchers worldwide, weve created FlexBeam, a revolutionary recovery device utilizing targeted infrared light therapy. Our mission is to bring the power of infrared light therapy into every home. More on FlexBeam: FlexBeam is the most powerful infrared therapy device of its kind. This non-pharmaceutical, non-invasive solution is already making a significant impact on the lives of many. With over 20,000 satisfied customers worldwide and endorsements from notable, global athletes, this wearable recovery device is changing the game of athletic recovery and health optimization. Developed with NASA-inspired technology, FlexBeam uses infrared light therapy to deliver powerful wavelengths of red (610-650nm) and infrared (800-850nm) light at up to 110mW/cm2, and a total optical power output of 5.5W. This powerful and targeted light stimulates your cells to produce more energy – so you can repair muscle, relieve pain, and recover faster.
Investor and Board Member
Feb 2025
To be more responsive, more efficient and make better decisions, BforCure allows public and industrial stakeholders to access biological information in real time, thanks to an innovative technology of rapid biodetection.
Investor and Board Member
Feb 2025
Puredrive Energy can call upon over 10 years of experience in the development, deployment and placement of battery technologies. With extensive experience in lead acid batteries through to the latest Lithium Ion batteries, Puredrive Energy is at the forefront of battery centric energy storage systems. Building upon its extensive market knowledge across Marine, Leisure, Sports , Mobility, UPS and Industrial Puredrive Energy has worked in conjunction with Puredrive to design and build a unique range of Energy Storage systems that are aimed at the Residential, Commercial and Community Battery Storage markets. Puredrive Energy’s unique (in house designed) battery is at the heart of all its products, and when packaged with other exclusive (Puredrive Energy) technical components, helps deliver a set of market leading products that are flexible, robust and offering excellent value for money. The Puredrive Energy range of products has been born out of over 10 years of market and customer experience. Consistently delivering richly featured products which meet the main needs of its customer’s requirements. Puredrive Energy Ltd is a British company that designs, develops, builds and distributes its own products to a broad spectrum of clients both home and abroad. With UK assembly of its products it is ideally placed to exploit its clearly established supply chain to maximum effect. Making delivery and distribution, in volume, to its UK market place speedy and simple. “PUREDRIVE ENERGY – A PURE JOY TO WORK WITH”
2024
Investor and Board Member
Oct 2024
LifeQ is the leading provider of biometrics and health information derived from wearable devices, helping people live healthier lives. By providing a 24/7 lens into the body, LifeQ’s solutions go beyond an everyday smartwatch, generating business-grade biometrics for consumers, athletes, and the acutely and chronically ill—detecting health problems and preventing illness. From cardiovascular disease and COVID to respiratory disorders and sleep apnea, LifeQ enables early detection and treatment of the world’s most debilitating diseases. Consumers, wearable device companies, insurers and reinsurers, health-tech companies, clinicians, researchers, and analytics companies all benefit from LifeQ’s powerful disease detection and prevention capabilities—representing the future of healthcare.
Show all 16 entries ↓
Investment activity
2023–2025 · 12 investments
202322024620254
Recent (last 2 years)Earlier